Follow us on Facebook

One on One Support

Health Concerns
VA Issues  

 


Information:
Notice: Website under construction,
Contact
HCVets@gmail.com  
 

Senate Veterans Affairs Meeting
Jetgun injections
&
Hepatitis C Transmission
Oct 22, 2015
Washington DC

May 2014 VA Hep C Treatment Guidelines
UPDATE: Feb 26, 2016-
Funding and Prioritization Status Update

UPDATE: March 2016
VA Hep C Treatment Guidelines
VA to treat all vets in system
 

Orange Count Registry
Vietnam vets blame 'jet guns' for their hepatitis C
By Lily Leung Feb. 14, 2016 
 

By Judith Graham
VA Extends New Hepatitis C Drugs to All Veterans in Its Health System

 
CBS News Investigates
Congress outraged over hepatitis C treatment VA can't afford
Dr. Raymond Schinazi played a leading role developing a drug that cures hepatitis C while working seven-eighths of his time for the VA
 
ibtimes.com| By amynordrum
 


Hepatitis C drug costing VA, DoD millions
By Patricia Kime, Staff writer
We're looking at a company who is milking a cash cow for everything it's worth," Sanders said. 
 


VA to outsource care for 180,000 vets with hepatitis C
Dennis Wagner, The Arizona Republic 12:27 a.m. EDT June 21, 2015
 


VA to outsource care for 180,000 vets with hepatitis C
, The Republic | azcentral.com 11:51 a.m. MST June 19, 2015
Dr. David Ross, the VA's director public-health pathogens programs, resigned from the working group. "I cannot in good conscience continue to work on a plan for rationing care to veterans," he wrote.
 


VA Region Stops Referring Patients To Outside Hospitals Thanks To Budget Shortfall
Michael Volpe Contributor ...According to a memo — the entire region has been forced to stop all “non-VA care” referrals due to a budget shortfall.
 

DisabledVeterans.org
OIG INVESTIGATES VA CHOICE PROGRAM PROBLEMS
Sen. Mark Kirk admitted the VA Choice Program is a failed joke in a letter to Secretary Bob McDonald despite attempts to fix it.
 

 
Denied Hep C VA dental care?
Please click here

 
Dried Hepatitis C Blood Exposure 11/23/2013 Weeks later inconspicuous blood transmits virus and more likely to cause accidental exposures to Hep C
 

Lack of Standards for
Mass Vaccinations
1970 Jetgun Nursing Instructions
 

2014 AASLD Study Hepatitis C not an STD

Home
Test the Rest Campaign
Meeting Sen. Sullivan's Office- Jetgun injections
Documentation & Surveillance Alerts
Military Hepatitis History  
Understanding The Liver 
VA Flow Sheet for Cirrhosis
VA Defines Risk Factors
 
Hep C & Pro-Prebiotic
Need to know-Grassroots Research
 
Blog Another12Weeks
One Vets' Journey Though Treatment
 

 Ask NOD
 What Would Veterans Do?
Blog for VA Claims
 


Help with VA Claims
 


 
Info: Plan Backfires-
VBA Fast Letter Boost Claims
 
Legal- Fed Regs state:
Judge decision may be relied upon
Cotant v. Principi, 17 Vet.App. 116, 134 (2003),
 
Service Connected Claims
# 1 Conclusion of Law 
# 2 Conclusion of Law 
 
More Claims
Jetgun Decisions
Hep C Decisions
 
Search Board of Appeals Website
BVA Jetgun Decisions
BVA Hepatitis C Decisions

Great Advice!  
After the jetgun win
What to do next

 


Hepatitis C Genotype Analysis: Results in a Large Veteran Population with Review of the Implications for Clinical Practice
...
© 2012 by the Association of Clinical Scientists, Inc.

((((((( COST TO READ FULL STUDY ))))))))...

Context Hepatitis C virus (HCV) infects up to 1.8% of the US general population, although the rate is significantly higher in military veterans at 5.4–20%. Early detection and accurate diagnosis are critical as chronic HCV infection can lead to liver cirrhosis and hepatocellular carcinoma. Genotype analysis has both therapeutic and prognostic importance in patients with HCV infections.

Objective We compare two versions of a commonly utilized platform for genotype analysis in HCV infections and review the implications of the results for clinical practice.

Design A retrospective review of 9401 genotype results from 2001–2010 were analyzed. All results were obtained from the James A. Haley VA Medical Center, a large referral veterans’ healthcare facility.

Results Genotype 1 was identified in 80.1% of samples, genotype 2 in 11.1%, genotype 3 in 7.4%, and genotype 4 in 1.2%. Genotypes 5 and 6 were rarely present in our patient population. Improvements in diagnostic methodologies over the study period resulted in shifts in genotype subtyping. Specifically, upgrading from the Versant HCV genotype assay (LIPA) (Siemens, Tarrytown, NY) to the newer version 2.0 assay resulted in an increase in identification of genotype 1a by 18.5%.

Conclusions Improved technologies lead to accurate genotype identification and subtyping, both of which have increasingly important prognostic and therapeutic implications. The clinical importance of these results in patients with HCV infections is reviewed.

(((( http://www.annclinlabsci.org/content/42/4/355.full

 

genotype assay

Which test is used to determine Veterans exposed to same source infections?

  1. Siemens Versant HCV genotype assay LIPA
  2. Siemens 2.0 assay

Specifically, upgrading from the Versant HCV genotype assay (LIPA) (Siemens, Tarrytown, NY) to the newer version 2.0 assay resulted in an increase in identification of genotype 1a by 18.5%.

 Improved technologies lead to accurate genotype identification and subtyping, both of which have increasingly important prognostic and therapeutic implications.

The clinical importance of  improved technology for HCV genotype assay offer accurate genotype identification and subtyping of blood borne pathogen such as Hepatitis C,

  1. important prognostic and therapeutic implications.
  2. Identify breaches in universal precautions 
  3. Identify same source encounter

Hepatitis C Genotype Analysis: Results in a Large Veteran Population with Review of the Implications for Clinical Practice
Abstract: © 2012 by the Association of Clinical Scientists, Inc.
The clinical importance of these results in patients with HCV infections is reviewed here. http://www.annclinlabsci.org/content/42/4/355.full
doubled since last year...